#None #Smartee Denti-Technology #ClearCorrect #Smartee GS

Smartee Denti-Technology's Year in Review: 2025

Smartee Denti-Technology has officially announced its annual review for 2025, marking a pivotal year that showcased the successful worldwide application of its exclusive mandibular repositioning technology. The company also highlighted the opening of a new European infrastructure and a strategic partnership with the Straumann Group.

The report emphasizes Smartee's transition from rapid growth to sustainable maturity, supported by advancements in three key pillars: clinical efficiency, global supply chain capacity, and professional training.

Clinical Milestone: Large-Scale Mandibular Repositioning

One of the standout achievements in 2025 was surpassing 100,000 cases utilizing Smartee’s GS mandibular repositioning technology. This milestone represents a significant testament to the effectiveness of using clear aligners for correcting severe dental misalignments, including Class II and III malocclusions, by focusing on mandibular repositioning rather than traditional extraction or surgical mechanics. Throughout the year, academic recognition for this approach accelerated, with the Journal of Aligner Orthodontics (JAO) publishing two articles on Smartee's protocols.

• - Article 2, 2025: A report by Dr. Xingxing Wang, Smartee’s Medical Director, discusses using transparent aligners to treat Class II malocclusions.
• - Article 4, 2025: A research study titled Working Mechanism and Clinical Management of Mandibular Advancement Repositioning Technology in Treating Three-Depth Malocclusion in Adult Patients, authored by Prof. Gang Shen and his orthodontic team, further explores clinical outcomes.

Operational Expansion and Strategic Partnerships

In 2025, Smartee ramped up production capabilities to meet increasing international demand, opening a smart manufacturing facility spanning 100,000 square meters. This facility is equipped with fully automated production lines and modular capabilities to support both in-house product lines and external partners. This production capacity was further validated in October through a strategic partnership with the Straumann Group, where Smartee will manufacture ClearCorrect, Straumann's range of transparent aligners, in select EMEA and APAC markets. This collaboration leverages Smartee's innovative infrastructure to offer customized production solutions while ensuring product consistency.

Groundbreaking R&D and AI Integration

In the fourth quarter of 2025, Smartee diversified its clinical portfolio with two major technological launches aimed at enhancing multidisciplinary care and workflow efficiency.

• - Smartee Sleep Aligners (released on October 1): Entering the sleep apnea management market, these night guards are designed for mild to moderate obstructive sleep apnea (OSA). The patented dual-hinge digital locking system and ultra-thin profile provide superior comfort compared to conventional devices. Clinically, the device aims to widen oropharyngeal airways by up to 23%. The line includes the SA variant for standalone sleep apnea therapy and SA Plus, a pioneering dual-action solution combining airway management with simultaneous orthodontic movement.

• - Smartee Live 3D (launched on October 30): To improve digital treatment planning efficiency, Smartee unveiled Live 3D, an AI-driven treatment planning tool. Utilizing deep learning algorithms, Live 3D generates initial 3D treatment designs in a mere 30 minutes. Together with Smartee LiveUpdate, this digital ecosystem enables clinicians to transition from case uploading to reviewing and finalizing treatment plans in under an hour, significantly streamlining overall production timelines.

Strengthened Global Footprint in Europe

To assist its growing partner network, Smartee established a dedicated subsidiary for the UK market and inaugurated a clinical assistance center in Stoke-on-Trent. This center provides region-specific treatment planning and clinical support, ensuring that digital treatment plans adhere to local medical standards and biomechanical preferences.

Commitment to Knowledge Exchange

Smartee's dedication to academic exchanges remained strong in 2025, participating in 27 major international congresses and organizing numerous exclusive training sessions. A global tour, stopping in 17 cities including Paris, Tokyo, and Rome, trained over 11,000 professionals on mandibular repositioning technology.

In the Chinese market, national training programs attracted 14,330 participants, with a focus on advanced orthodontic education extended to emerging markets such as Weifang, Lanzhou, and Kunming, fostering growth in lower-tier regions.

Emphasis on early pediatric orthodontics was highlighted by summits in Singapore, Melbourne, and Disneyland® Paris, along with an international symposium focusing on orofacial myofunctional therapy in Shanghai.

Simultaneously, Smartee has progressed on its commitments to environmental, social, and governance (ESG) standards, implementing solar energy projects projected to reduce CO₂ emissions by 209 tons annually, alongside digital governance systems aimed at improving employee welfare.

About Smartee Denti-Technology

Founded in 2004, Smartee is a global leader in digital orthodontics and transparent aligner manufacturing, providing services to over 99,000 partner physicians across 57 countries, supported by four R&D centers and four production sites in China and Spain. Their portfolio includes the Smartee GS (mandibular repositioning), Smartee GE, and Smartee Kinder/Teen series.